We are led by an experienced leadership team with a proven track record in the biopharmaceutical industry. Collectively, our leadership team has contributed to drug discovery and development as well as approval, launch and commercialization of multiple specialty medicines.

Polygon
Lynne Powell
Chief Executive Officer
Polygon
Katalin Ferenczi
General Manager, Europe
Polygon
Dr. Andreas Maetzel
Chief Medical Officer
Polygon
Dr. Elizabeth Manning Duus
Vice President of Clinical Development
Polygon
Marion McGlynn
Vice President of Project and portfolio management